4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001104659-22-097876
Chief Scientific Officer acquired 5,794 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Sethuraman Natarajan · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-09-01 | Grant or award : show line 1 in the form | +5,794 | 162,144 | D |
Loading xslF345X03/tm2225276-2_4seq1.xml…